Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy with or without intralesional vitamin D3 for recalcitrant warts
IRCT20200513047434N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vitamin d in Wart (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Complete clinical clearance of recalcitrant warts. Started May 2020; status: completed.
02
Drugs
vitamin d
03
Conditions
Wart
Beyond the preview
Go deeper on IRCT20200513047434N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200513047434N1.